Animal Health Solutions

Q2 2021

Animal Health Solution - a Covetrus magazine for veterinary professionals

Issue link: https://www.e-digitaleditions.com/i/1369858

Contents of this Issue

Navigation

Page 8 of 47

9 Q2 2021 | Animal Health Solutions The safety of a pharmacy's final compounded product is the culmination of relevant rules and regulations, the pharmacy's procedures and expertise, and teamwork with veterinarians. Adverse events related to compounded products from 503A facilities are voluntarily reported to the FDA by pharmacists and veterinarians, although in some states, it may be mandatory. 503B compounders are required to report adverse events related to their compounded products to the FDA. 6 Where should veterinarians order compounded medications and go for more information? In general, veterinarians should seek compounding pharmacies that specialize in veterinary medicine, as these pharmacies typically have more specialized experience pertinent to veterinary customers. Several additional resources are available within the full-length version of this article at cliniciansbrief.com/article/ navigating-compounding-regulations-what-veterinary- community-needs-know. Compounding law is actively evolving; the more practicing veterinarians know about this landscape, the more they can be involved in shaping it. State veterinary medical associations and SBOP can often help solicit veterinary opinion and help make this heard. Proposed federal guidelines also solicit feedback and input, which is particularly important for the veterinary community to get involved in, as there are so many unique situations in the veterinary field that may not be considered without input from veterinarians in practice. For veterinary professionals, the oversight and regulation of compounding is important not only for legal reasons but for ethical ones as well. Compounded drugs continue to be a valuable part of veterinary practice. In part three of this series, the current quality standards of veterinary compounding and how compliance is facilitated will be discussed. Disclaimer: This article was written by a clinical veterinary pharmacist. The author is not a lawyer; therefore, this article should not be used as legal advice. Sources: 1. US Food & Drug Administration. Q&A: Draft GFI #256 - compounding animal drugs from bulk drug substances. US FDA website. https://www.fda.gov/animal-veterinary/ animal-drug-compounding/qa-draft-gfi-256-compounding-animal-drugs-bulk-drug- substances. Updated March 9, 2020. Accessed September 24, 2020. 2. US Food & Drug Administration. Animal drug compounding. FDA website. https:// www.fda.gov/animal-veterinary/unapproved-animal-drugs/animal-drug-compounding. Updated January 8, 2020. Accessed March 12, 2021. 3. US Food & Drug Administration. Facts about the current good manufacturing practices (CGMPs). https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts- about-current-good-manufacturing-practices-cgmps. US FDA website. Updated June 25, 2018. Accessed September 23, 2020. 4. National Association of Boards of Pharmacy. Model pharmacy act/rules. NABP website. Accessed September 23, 2020. 5. United States Pharmacopeia. Recognition of USP compounding standards. USP website. https://www.usp.org/compounding/legal-considerations. Accessed September 23, 2020. 6. The FDA Group. 503A vs. 503B: a quick-guide to compounding pharmacy designations & regulations. FDA Group website. Published October 12, 2017. Accessed September 23, 2020. 7. H.R.3204 - Drug Quality and Security Act. https://www.congress.gov/bill/113th- congress/house-bill/3204. Accessed September 23, 2020. 8. US Food & Drug Administration. Questions and answers: outsourcing facility registration. US FDA website. https://www.fda.gov/drugs/human-drug-compounding/ questions-and-answers-outsourcing-facility-registration. Accessed September 23, 2020. 9. US Food & Drug Administration. Information for outsourcing facilities. US FDA website. https://www.fda.gov/drugs/human-drug-compounding/information- outsourcing-facilities. Updated September 10, 2020. Accessed September 23, 2020. 10. US Food & Drug Administration. Q7 good manufacturing practice guidance for active pharmaceutical ingredients: guidance for industry. US FDA website. https://www. fda.gov/media/71518/download. Accessed September 23, 2020. 11. Accreditation Commission for Health Care. Compounding pharmacy accreditation. ACHC website. https://www.achc.org/compounding-pharmacy.html. Accessed September 23, 2020. About the author Jennifer Kobylarczyk, PharmD, FSVHP, is a clinical consultant pharmacist at and the owner of Avant Pharm Care in Lakewood, Colorado, as well as a compounding pharmacist at Wise Pharmacy. She earned her PharmD from University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. She is also a clinical veterinary pharmacist with Plumb's Veterinary Drugs and has received her veterinary pharmacotherapy certification and PCCA compounding certificate.

Articles in this issue

Links on this page

Archives of this issue

view archives of Animal Health Solutions - Q2 2021